rosiglitazone has been researched along with Canine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frazier, SA; Guerrero, TA; McKemie, DS; Rodriguez, CO; Skorupski, KA | 1 |
| Allstadt Frazier, S; Guerrero, TA; Kass, PH; LaChapelle, H; McKemie, DS; Rodriguez, CO; Skorupski, KA | 1 |
1 trial(s) available for rosiglitazone and Canine Diseases
| Article | Year |
|---|---|
Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer-bearing dogs.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Hypoglycemic Agents; Injections, Intravenous; Male; Neoplasms; Rosiglitazone; Thiazolidinediones | 2014 |
1 other study(ies) available for rosiglitazone and Canine Diseases
| Article | Year |
|---|---|
Evaluation of an extractionless high-performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of rosiglitazone in canine plasma.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Carboplatin; Chromatography, High Pressure Liquid; Dog Diseases; Dogs; Female; Half-Life; Male; Neoplasms; Rosiglitazone; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazolidinediones | 2011 |